Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2

被引:10
作者
Behnam, Mira A. M. [1 ]
机构
[1] Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany
关键词
SARS-CoV; SARS-CoV-2; Conformational selection; Viral protease; Antiviral drugs; CRYSTAL-STRUCTURES; M-PRO; INHIBITORS; DESIGN; DIMERIZATION; DISCOVERY; DOMAIN; SITE;
D O I
10.1016/j.biochi.2021.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The main protease (M-pro) of SARS-CoV and SARS-CoV-2 is a key enzyme in viral replication and a promising target for the development of antiviral therapeutics. The understanding of this protein is based on a number of observations derived from earlier x-ray structures, which mostly consider substrates or ligands as the main reason behind modulation of the active site. This lead to the concept of substrate-induced subsite cooperativity as an initial attempt to explain the dual binding specificity of this enzyme in recognizing the cleavage sequences at its N- and C-termini, which are important processing steps in obtaining the mature protease. The presented hypothesis proposes that structural heterogeneity is a property of the enzyme, independent of the presence of a substrate or ligand. Indeed, the analysis of M(pro )structures of SARS-CoV and SARS-CoV-2 reveals a conformational diversity for the catalytically competent state in ligand-free structures. Variation in the binding site appears to result from flexibility at residues lining the S-1 subpocket and segments incorporating methionine 49 and glutamine 189. The structural evidence introduces "structure-based recognition" as a new paradigm in substrate proteolysis by M-pro. In this concept, the binding space in subpockets of the enzyme varies in a non-cooperative manner, causing distinct conformations, which recognize and process different cleavage sites, as the N- and C-termini. Insights into the recognition basis of the protease provide explanation to the ordered processing of cleavage sites. The hypothesis expands the conformational space of the enzyme and consequently opportunities for drug development and repurposing efforts. (C) 2021 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 68 条
[41]   SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity [J].
Muramatsu, Tomonari ;
Takemoto, Chie ;
Kim, Yong-Tae ;
Wang, Hongfei ;
Nishii, Wataru ;
Terada, Takaho ;
Shirouzu, Mikako ;
Yokoyama, Shigeyuki .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) :12997-13002
[42]   Subsite cooperativity in protease specificity [J].
Ng, Natasha M. ;
Pike, Robert N. ;
Boyd, Sarah E. .
BIOLOGICAL CHEMISTRY, 2009, 390 (5-6) :401-407
[43]   Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology [J].
Nitsche, Christoph ;
Zhang, Linlin ;
Weigel, Lena F. ;
Schilz, Jonas ;
Graf, Dominik ;
Bartenschlager, Ralf ;
Hilgenfeld, Rolf ;
Klein, Christian D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (01) :511-516
[44]   UCSF chimera - A visualization system for exploratory research and analysis [J].
Pettersen, EF ;
Goddard, TD ;
Huang, CC ;
Couch, GS ;
Greenblatt, DM ;
Meng, EC ;
Ferrin, TE .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) :1605-1612
[45]   ON SIZE OF ACTIVE SITE IN PROTEASES .I. PAPAIN [J].
SCHECHTER, I ;
BERGER, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 27 (02) :157-+
[46]   The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain [J].
Shi, JH ;
Song, JX .
FEBS JOURNAL, 2006, 273 (05) :1035-1045
[47]   Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme - Defining the extra domain as a new target for design of highly specific protease inhibitors [J].
Shi, JH ;
Wei, Z ;
Song, JX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :24765-24773
[48]   Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease [J].
Shi, Jiahai ;
Sivaraman, J. ;
Song, Jianxing .
JOURNAL OF VIROLOGY, 2008, 82 (09) :4620-4629
[49]   Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors [J].
Shimamoto, Yasuhiro ;
Hattori, Yasunao ;
Kobayashi, Kazuya ;
Teruya, Kenta ;
Sanjoh, Akira ;
Nakagawa, Atsushi ;
Yamashita, Eiki ;
Akaji, Kenichi .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) :876-890
[50]   pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer:: Molecular dynamics simulations and multiple X-ray structure analyses [J].
Tan, JZ ;
Verschueren, KHG ;
Anand, K ;
Shen, JH ;
Yang, MJ ;
Xu, YC ;
Rao, ZH ;
Bigalke, J ;
Heisen, B ;
Mesters, JR ;
Chen, KX ;
Shen, X ;
Jiang, HL ;
Hilgenfeld, R .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 354 (01) :25-40